The Problem with NAD+ IV Therapy
NAD+ IV therapy has been the gold standard for NAD+ delivery, but it comes with significant drawbacks:
Cost: Typical IV NAD+ sessions cost €500-1,500 per treatment, with protocols requiring multiple sessions per month. Annual costs can exceed €10,000.
Time: Each IV infusion takes 2-4 hours, requiring a clinic visit and supervision.
Availability: Limited to clinic locations, often requiring advance booking.
Side Effects: IV infusions can cause chest tightness, nausea, and discomfort during administration, particularly at higher infusion rates.
Inconsistency: NAD+ levels spike dramatically during infusion, then decline. This pattern differs from the body's natural, steady-state NAD+ metabolism.
For researchers studying NAD+ biology, these limitations make IV therapy impractical for sustained, consistent protocols.
ORYN NAD+ Pen: Daily Precision Dosing
The ORYN NAD+ Pen delivers 500mg of pharmaceutical-grade NAD+ in a pre-mixed pen system designed for consistent, daily administration:
Subcutaneous Delivery: Bypasses the digestive system entirely, providing high bioavailability without the complexity of IV access.
Consistent Levels: Daily dosing maintains steadier NAD+ levels compared to the spike-and-crash pattern of periodic IV infusions.
At-Home Convenience: No clinic visits, no appointments, no 2-4 hour sessions. Administration takes minutes.
Cost: €189 per month vs €500-1,500+ per IV session. Over a year, savings can exceed €10,000.
The ORYN NAD+ pen is ideal for researchers who need consistent, daily NAD+ delivery with adjustable dosing flexibility.
NovaDose System: Advanced Daily Microdosing
The NovaDose NAD+ system represents ORYN's most advanced delivery platform:
Cartridge-Based Design: Uses replaceable cartridges in an aluminium pen body, offering a premium, sustainable dosing experience.
Daily Microdosing: Engineered specifically for precise daily microdoses, aligning with the body's natural NAD+ metabolism patterns.
Near 100% Bioavailability: The cartridge system and micro-needle technology maximise absorption and minimise waste.
Korean Pharmaceutical Grade: NAD+ sourced from pharmaceutical-grade Korean manufacturing facilities.
At €299, the NovaDose system costs less than a single IV infusion session while providing a full month of daily NAD+ delivery. For sustained research protocols, it represents an order-of-magnitude improvement in cost-effectiveness.
